Determination of gouty arthritis' biomarkers in human urine using reversed-phase high-performan

来源 :Journal of Pharmaceutical Analysis | 被引量 : 0次 | 上传用户:jinkejinlv
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Creatinine, uric acid, hypoxanthine and xanthine are important diagnostic biomarkers in human urine for gouty arthritis or renal disease diacrisis. A simple method for simultaneous determination of these biomarkers in urine based on reversed-phase high-performance liquid chromatography(RPHPLC) with ultraviolet(UV) detector was proposed. After pretreatment by dilution, centrifugation and filtration, the biomarkers in urine samples were separated by ODS-BP column by elution with methanol/50 mM NaH2PO4 buffer solution at pH 5.26(5:95). Good linearity between peak areas and concentrations of standards was obtained for the biomarkers with correlation coefficients in the range of 0.9957–0.9993.The proposed analytical method has satisfactory repeatability(the recovery of data in a range of creatinine, uric acid, hypoxanthine and xanthine was 93.49–97.90%, 95.38–96.45%, 112.46–115.78% and90.82–97.13% with standard deviation of o5%, respectively) and the limits of detection(LODs, S/NZ3)for creatinine, uric acid, hypoxanthine, and xanthine were 0.010, 0.025, 0.050 and 0.025 mg/L,respectively. The established method was proved to be simple, accurate, sensitive and reliable for the quantitation of gouty arthritis’ biomarkers in human urine samples. The ratio of creatinine to uric acid was found to be a possible factor for assessment of gouty arthritis. A simple method for simultaneous determination of these biomarkers in urine based on reversed-phase high-performance liquid chromatography (RPHPLC) with ultraviolet ( UV pre-treatment was proposed. After pretreatment by dilution, centrifugation and filtration, the biomarkers in urine samples were separated by ODS-BP column by elution with methanol / 50 mM NaH2PO4 buffer solution at pH 5.26 (5:95) areas and concentrations of standards was obtained for biomarkers with correlation coefficients in the range of 0.9957-0.9993. The proposed analytical method has satisfactory repeatability (the recovery of data in a range of creatinine, uric acid, hypoxanthine and xanthine was 93.49-97.90% , 95.38-96.45%, 112.46-115.78% and90.82-97.13% with standard deviation of o5%, respectively) and the limits of detection (LODs, S / NZ 3) for creatinine, uric acid, hypoxanthine, and xanthine were 0.010, 0.025, 0.050 and 0.025 mg / L, respectively. The established method was proved to be simple, accurate, sensitive and reliable for the quantitation of gouty arthritis’ biomarkers in human urine samples. The ratio of creatinine to uric acid was found to be a possible factor for assessment of gouty arthritis.
其他文献
目的分析淋巴血管侵犯(LVI)对高级别T1期膀胱癌患者初次施行经尿道膀胱肿瘤电切术(TURBT)预后的影响。方法选择初次行TURBT且术后病理结果显示LVI阳性的高级别T1期膀胱癌患者35例(观察组)和初次行TURBT且术后病理结果显示LVI阴性的高级别T1期膀胱癌患者70例(对照组),比较两组患者肿瘤复发率、肿瘤进展率、肿瘤无复发生存时间(RFS)、总生存时间(OS)。结果观察组随访15~ 71
1例55岁男性患者因高血压合并2型糖尿病伴肝功能异常(丙氨酸转氨酶74 U/L,γ谷氨酰胺转肽酶712 U/L]和低血钾(3.40 mmol/L),给予硝苯地平缓释片30 mg、1次/d口服,贝那普利10 mg、1次/d口服,阿卡波糖片25 mg/次、三餐前嚼服,复方甘草酸苷60 ml(120 mg)/d静脉滴注,氯化钾片1.0 g、3次/d口服。用药第14天患者出现下肢无力伴全身肌肉疼痛,四肢肌
2例女性患者(例1,61岁;例2, 48岁)因宫颈癌使用伊立替康200 mg联合洛铂50 mg化疗。例1在第2周期化疗后第9天出现腹泻、IV度骨髓抑制及败血症伴感染性休克;例2在第1周期化疗后第6天出现腹泻、IV度骨髓抑制伴发热,后继发败血症。经止泻、抗感染、免疫支持治疗,5 d后腹泻停止,白细胞计数、血红蛋白含量及血小板计数分别于10、6 d后明显好转,败血症分别于20、6 d后有效控制。
期刊
目的对比老年患者应用心律植入装置(EPD)围手术期给予不同抗凝或抗血小板方案对术后囊袋血肿的意义。方法选择2012年2月至2015年2月收治的正服用抗凝或抗血小板药物且需要应用EPD的410例老年患者,依据围手术期给予不同抗凝或抗血小板治疗的方案分组:双重抗血小板药物(DAP)治疗组(DAP组)114例、低分子量肝素(LMWH)桥接治疗组(LMWH组)98例、单用阿司匹林(ASA)治疗组(ASA组
期刊
期刊